Day 1: Monday October 3, 2011
|
|
8:00
|
 Welcome Overview
Civic Auditorium
- Bernard Siegel JD, Genetic Policy Institute
- Richard Jove PhD, City of Hope
- Shlomo Melmed, MD, FRCP, Cedars-Sinai
- Paul Patterson PhD, California Institute of Technology
- Carmen Puliafito MD, MBA, USC Keck School of Medicine
- Jonathan Thomas, PhD, JD, California Institute for Regenerative Medicine
|
|
8:30
|
Keynote Address
Civic Auditorium
CIRM's Translational Roadmap to Stem Cell Cures
- Alan Trounson, PhD, California Institute for Regenerative Medicine
8:30-9:00
|
|
9:00
|
Plenary Discussion
Civic Auditorium
How Stem Cells are Transforming Medicine - ISSCR Perspectives
9:00-10:30
Moderator:
- Heather Rooke PhD, International Society for Stem Cell Research
Speakers:
- Arnold Kriegstein, MD, PhD, University of California - San Francisco
- Ann Tsukamoto, PhD, StemCells, Inc.
- Lawrence S. B. Goldstein, PhD, University of California- San Diego
|
|
10:45
|
Science Keynote Address
Civic Auditorium
Evidence-based development of stem cell therapies
Lawrence S. B. Goldstein, PhD, University of California- San Diego
10:45-11:30
|
|
11:30
|
KEYNOTE Addresses
Civic Auditorium
Translational Medicine: Key to Progress or Bridge to Nowhere?
Andrew S. Grove, PhD, Former CEO, Intel Corporation
11:30-12:30
|
|
2:30
|
focus Session
Stem Cell Translational Report - Diabetes
Ballroom B
2:30-3:30 - Progress Session
Moderator:
- Camillo Ricordi MD, Diabetes Research Institute, University of Miami
Speakers:
- Meri Firpo, University of Minnesota
- Eugene Brandon PhD, ViaCyte
- Lorraine Stiehl, Juvenile Diabetes Research Foundation
|
|
2:30
|
focus Session
Stem Cell Progress Report - HIV/AIDS
Ballroom C
2:30-3:30 - Progress Session
Moderator:
- Paula Cannon PhD, USC Keck School of Medicine
Speakers:
- John Zaia MD, Beckman Research Institute
- Jeff Sheehy, ICOC California Institute for Regenerative Medicine
- Irvin S.Y. Chen PhD, University of California, Los Angeles
|
|
2:30
|
focus Session
Strategies and Tactics in the Battleground States
Ballroom D
2:30-3:30 - Society Session
Moderator:
- Don Reed, American for Cures Foundation
Speakers:
- Roman Reed, Roman Reed Foundation
- Jonathan M.W.Slack, Ph.D., F.Med.Sci., Stem Cell Institute, University of Minnesota
- Bernard Siegel, JD, GPI and Stem Cell Action Coalition
|
|
2:30
|
focus Session
Unleashing Regenerative Medicine to Extend the Healthy Lifespan: Technological Issues and Commercial Opportunities
Ballroom E
2:30-3:30 - Industry Session
Moderator:
- Aubrey de Grey PhD, SENS Foundation
Speakers:
- Michael West, PhD, BioTime
- Xianmin Zeng, PhD, Buck Institute for Aging Research
- Stephen Minger PhD, GE Healthcare
|
|
4:00
|
Concurrent Session
Understanding the legal and policy challenges to stem cell research- Sherley v. Sebelius and beyond
Ballroom B
4:00-5:00 -Society Session
Moderator:
- Alan Jakimo JD, Sidley Austin, LLP
Speakers:
- Russell Korrobkin, UCLA School of Law
- Jeanne F. Loring PhD, The Scripps Research Institute
- Hank Greely JD, Stanford Law School
|
|
4:00
|
CONCURRENT SESSION
The Outlook for the Cord Blood- All Things Considered
Ballroom C
4:00-5:00 -Society Session
Moderator:
- Charles F. Simmons Jr. MD, Cedars Sinai Medical Center
Speakers:
- C. Michael Cotten MD, MHS, Duke University Health System
- Jennifer Willert MD, Rady Children's Hospital San Diego
- Michael Boo JD, National Marrow Donor Program
|
|
4:00
|
CONCURRENT SESSION
Translational and Clinical Studies of Stem Cells for Heart Regeneration
Ballroom D
4:00-5:00 - Science Session
Moderator:
- Eduardo Marban MD, PhD, Cedars Sinai Heart Institute
Speakers:
- Arnold I. Caplan PhD, Case Western Reserve University
- Henry Sucov, PhD, USC Keck School of Medicine
|
|
4:00
|
CONCURRENT SESSION
Economic Development: Stem Cells and Regenerative Medicine as an Engine for Economic Growth
Ballroom E
4:00-5:00 - Industry Session
Moderator:
- Drew Lyall, Stem Cell Network, Canada
Speaker:
- Michael H. May, Centre for Commercialization of Regenerative Medicine, Canada
- Elona Baum, California Institute for Regenerative Medicine, California
- Kevin Price, Scottish Stem Cell Network
|
Day 2: Tuesday October 4, 2011
|
|
8:30
|
welcome
Civic Auditorium
Bernard Siegel, JD, Genetics Policy Institute
David Fransen, Consulate General of Canada
David Warburton, Children's Hospital Los Angeles
8:30-8:45
|
|
8:45
|
Science Keynote Address
Civic Auditorium
Stem cells, reprogramming and personalized medicine: promise, problems, reality
Rudolf Jaenisch, MD, Member, Whitehead Institute, MIT
8:45-9:30
|
|
9:30
|
Plenary Discussion
Harnessing Regenerative Medicine for US Service-members
Civic Auditorium
Major General James K. Gilman, US Army Medical Research and Material Command
9:30-10:15
|
|
10:30
|
Industry Keynote Address
Civic Auditorium Foyer
Cell Therapy Industry: Billion Dollar Global Business with Unlimited Potential
Chris Mason, MBBS, PhD, FRCS,University College London
10:30-11:15
|
|
11:15
|
Industry Keynote Address
Civic Auditorium
The Transformational Potential of Regenerative Medicine, and How It Will Change Healthcare As We Know It
Gil Van Bokkelen, PhD, Chairman and CEO, Athersys, Inc.
11:15-12:00
|
|
12:15
|
Concurrent Session
A Global Approach to Clinical Trials - Pros and Cons
Ballroom B
12:15-1:15 - Industry Session
Moderator:
- Kurt C. Gunter, Hospira, Inc.
Speakers:
- Wise Young MD, PhD, Rutgers, The State University of New Jersey
- Mark J. Tager, MD, Stemedica Cell Technologies, Inc.
- Armand Keating, MD, FRCP, University of Toronto
|
|
12:15
|
CONCURRENT SESSION
Mixing Modalities: Cells, Genes and Devices
Ballroom C
12:15-1:15 - Industry Session
Moderator:
- Scott R. Burger MD, Advanced Cell & Gene Therapy, LLC
Speakers:
- Don Kohn MD, University of California, Los Angeles
- Michael C. Holmes, PhD, Sangamo BioSciences, Inc.
|
|
12:15
|
CONCURRENT SESSION
Safety Issues in Stem Cell Therapies: Immunogenecity, Tumorgenicity and Genetic Stability
Ballroom D
12:15-1:15 - Science Session
Moderator:
- Martin Pera, USC
Speakers:
- Nissim Benvenisty MD, PhD, Hebrew University of Jerusalem
- Yang Xu PhD, University of California, San Diego
- Kun Zhang PhD, University of California, San Diego
|
|
12:15
|
CONCURRENT SESSION
Stem Cell Politics: The Advocacy Agenda for 2012
Ballroom E
12:15-1:15 - Society Session
Moderator:
- James E. Doyle, Former Governor, State of Wisconsin, Of Counsel, Foley & Lardner, LLP
Speakers:
- John Hlinko, Hlinko Consulting
- Mary Woolley, Research America
- Kevin M. Wilson, The American Society for Cell Biology
|
|
1:15
|
Workshop:
Stem Cells Below the Equator- South America Roundtable
Ballroom D
1:15-2:30
- Mari Cleide Sogayar, University of São Paulo
- Santiago Miriuka, MD MSc, FLENI, Buenos Aires, Argentina
- Lygia V. Pereira, PhD, University of São Paulo, Brazil
|
|
1:15
|
Workshop:
Empowering Advocates and Researchers Through Social Media and the Blogosphere
Ballroom E
1:15-2:30
Moderator:
- John Hlinko, Hlinko and Associates
Speakers:
- Don Reed, Americans for Cures Foundation
- Paul Knoepfler, University of California Davis
- Amy Adams, California Institute for Regenerative Medicine
|
| 2:30 |
FOCUS SESSION
A Consumer Guide - Clinical Uses of Stem Cells Derived from Cord Blood
Ballroom B
2:30-3:30 - Industry Session
Moderator:
-Ian K. McNiece PhD, University of Miami
Speakers:
- Mary Schneider, Children's Neurobiological Solutions (CNS) Foundation
- Yoon-Sun Yang MD, PhD, MEDIPOST Co., Ltd.
- Claudia Zylberberg PhD, Akron Biotech
|
|
2:30
|
focus Session
Commercial Stem Cell Standardization Solutions
Ballroom C
2:30-3:30 - Industry Session
Moderator:
- Scott R. Burger, MD, Advanced Cell & Gene Therapy, LLC
Speakers:
- Roberto Herrera, Cell Line Genetics, LLC
- Anne L. Plant PhD, National Institute of Standards and Technology
- Raymond H. Cypess, DVM, PhD, American Type Culture Collection (ATCC)
|
|
2:30
|
FOCUS SESSION
Stem Cell Science - Regenerating Whole Organs
Ballroom D
2:30-3:30 - Science Session
Moderator:
David Warburton, Children's Hospital Los Angeles
Speakers:
- Tracy Grikscheit MD, USC Keck School of Medicine
- James Yoo MD, PhD, Wake Forest Institute for Regenerative Medicine
|
|
2:30
|
FOCUS SESSION
Stem Cell Translational Report- Spinal Cord Injury, Paralysis and MS
Ballroom E
2:30-3:30 - Progress Session
Moderator:
- Arlene Chiu PhD, City of Hope
Speakers:
- Chris Airriess,PhD, California Stem Cell
- Aileen Anderson PhD, University of California, Irvine
- Sam Schmidt, Sam Schmidt Paralysis Foundation
|
|
3:45
|
Concurrent Session
Stem Cells for Modeling Neurological Disorders
Ballroom B
3:45-4:45 - Science Session
Moderators:
- Margaret Sutherland, PhD, NIH/NINDS
- Clive Svendsen PhD, Cedars-Sinai Regenerative Medicine Institute
Speakers:
- Arnold Kriegstein MD, PhD, University of California, San Francisco
- Wange Lu PhD, USC Keck School of Medicine
- Dimitri Krainc, MD, PhD, Harvard Medical School
|
|
3:45
|
CONCURRENT SESSION
The Emergence of Academic Interdisciplinary Stem Cell Institutes as Engines for Translational Progress
Ballroom C
3:45-4:45 - Society Session
Moderator:
- Edward W. Holmes, MD, Sanford Consortium for Regenerative Medicine
Speakers:
- Brock Reeve PhD, Harvard Stem Cell Institute
- Philip A. Pizzo, MD, Stanford University School of Medicine
- Sidney H. Golub, Ph.D., UCI School of Medicine
|
|
3:45
|
CONCURRENT SESSION
GMP,GCP, GTP- Taking Cells to the Clinic- Scientific Perspectives
Ballroom D
3:45-4:45 - Science Session
Moderator:
- Scott R. Burger, MD, Advanced Cell & Gene Therapy, LLC
Speakers:
- Larry Couture PhD, City of Hope
- Gerhard Bauer, University of California, Davis
- Alex Kharazi, MD, PhD, Stemedica Cell Technologies, Inc.
|
|
3:45
|
CONCURRENT SESSION
The Paradigm Shift to Cell Based Medicine: How Investors Can Discern True Value
Ballroom E
3:45-4:45 - Industry Session
Moderator:
- Jason Kolbert, Neostem
Speakers:
- Zami Aberman, Pluristem Therapeautics, Inc.
- Keith Murphy, Organovo, Inc.
- Bobby W. Sandage, PhD, Coronado Biosciences, Inc.
|
Day 3: Wednesday October 5, 2011
|
|
8:00
|
Plenary Discussion
State of the States: Research Programs, Public Funds and Interstate Collaborations
(Perspectives from Leaders of Interstate Alliance for Stem Cell Research)
Ballroom E
8:00-9:00
Moderator:
- Geoffrey Lomax PhD, California Institute for Regenerative Medicine
Speakers:
- Beth E. Roxland JD, M. Bioethics, New York State Task Force on Life and the Law
- Marianne Horn JD, Connecticut Department of Public Health
- Melissa J. Lopes Esq, Harvard University
|
|
9:00
|
PLENARY DISCUSSION
Leading International Institutions and Their Strategies for Advancing Regenerative Medicine
Ballroom E
9:00-10:00
Moderator:
- Alain Vertes PhD, London Business School
Speakers:
- Norio Nakatsuji DSc, Kyoto University
- Prof.Dr.med.Frank Emmrich, Translational Centre for Regenerative Medicine
- Karl-Henrik Grinnemo, M.D., Ph.D., Karolinska Institute
|
| 11:00 |
focus Session
Healing Our Wounded Warriors: Armed Forces Investment in Regenerative Medicine
Ballroom B
11:00-12:00 - Industry Session
- Terry R. Irgens RPh, MS, CAAMA, Armed Forces Institute of Regenerative Medicine
|
| 11:00 |
FOCUS SESSION
Forging Relationships between Industry and Regulators
Ballroom C
11:00-12:00 - Industry Session
Moderator:
- Ellen Feigal, MD, California Institute for Regenerative Medicine
Speakers:
- Michael Werner Esq., Holland & Knight
- Raj Puri MD, FDA
- Melissa Carpenter, PhD, Carpenter Group Consulting, Inc.
|
| 11:00 |
FOCUS SESSION
Stimulating Endogenous Stem Cells
Ballroom D
11:00-12:00 - Science Session
Moderator:
- Paul Patterson PhD, California Institute of Technology
Speakers:
- Dave DiGiusto PhD, City of Hope
- Benjamin Deverman PhD, California Institute of Technology
- Abdel Benraiss, PhD, University of Rochester
|
|
11:00
|
FOCUS SESSION
Stem Cell Translational Report- Diseases of the Eye
Ballroom E
11:00-12:00 - Progress Session
Moderator:
- Dennis Clegg PhD, University of California, Santa Barbara
Speakers:
- Peter Coffey, The London Project to Cure Blindness, UCL Institute of Ophthalmology
- Mark Humayun MD, PhD, University of Southern California
- Gary Rabin, CEO, Advanced Cell Technology
|
|
12:00
|
Tech Transfer Workshop:
How to Turn Your Lab Research into Valuable Intellectual Property
Ballroom D
1:15-2:30
- Samuel Woodley, JD, PhD, Fish & Richardson
- Peter Ludwig, Principal, Fish & Richardson
- Christopher T. Moulding, USC Stevens Institute for Innovation
|
| 12:00 |
Luncheon Workshop
Financing Pathways for Stem Companies and Novel Funding Options
Ballroom E
2:30-3:30 - Industry Session
- Robin L. Smith, MD, MBA, NeoStem, Inc
- Gregory Bonfiglio, Proteus Venture Partners
|
|
1:00
|
CONCURRENT SESSION
International Government Collaborations for Funding
Ballroom B
1:00-2:00 - Society Session
Moderator:
- Nancy Koch, California Institute for Regenerative Medicine
Speakers:
- Cindy Bell, PhD, Genome Canada
- Subramanian Ramaswamy, Institute for Stem Cell Biology and Regenerative Medicine
|
|
1:00
|
CONCURRENT SESSION
Promising Science from Industry Labs
Ballroom C
1:00-2:00 - Science Session
Moderator:
- David Eveleth, Ph.D., Pfizer Inc., La Jolla Laboratories
Speakers:
- Allen Davidoff, Ph.D., Stem Cell Therapeutics Corp
- Stephen L. Huhn, MD, FAAP, FACS, StemCells, Inc.
- Simon Craw, PhD, International Stem Cell Corporation
|
|
1:00
|
CONCURRENT SESSION
Stem Cell Translational Report- ALS, Parkinson's and other Neurological Diseases
Ballroom D
11:00-12:00 - Progress Session
- Evan Y. Snyder MD, PhD, FAAP, Sanford Burnham Medical Research Institute
- Clive Svendsen PhD, Cedars-Sinai Regenerative Medicine Institute
- Frank Laferla, PhD, University of California, Irvine
|
|
1:00
|
CONCURRENT SESSION
Emerging Trends in Cell Banking
Ballroom E
1:00-2:00 - Industry Session
Moderator:
- David Smith, MBA, Lonza Walkersville, Inc
Speakers:
- Chris Hempel, Addi & Cassi Fund
- Calvin L. Cole, StemCyte North America
- Joseph C. Laning PhD, University of Massachusetts Medical School
|
|
2:00
|
Concurrent Session
Key Clinical Trial Updates
Ballroom B
1:15-2:15 - Industry Session
- Karen Aboody MD, City of Hope
- Martin McGlynn, StemCells Inc.
- Jane Lebkowski PhD, Geron Corporation
|
|
2:00
|
CONCURRENT SESSION
Hospital and Clinician Perspectives on Stem Cells and Regenerative Medicine
Ballroom C
2:00-3:00 - Society Session
Moderator:
- Theodore G. Krontiris MD, PhD, Comprehensive Cancer Center, City of Hope
Speakers:
- Leon Fine MD, Cedars-Sinai Medical Center
- Roger De Filippo, MD, FAAP, Children’s Hospital of Los Angeles
- James J. Kovach, MD, JD, CHA Health Systems
|
|
2:00
|
CONCURRENT SESSION
New Stem Cell Discoveries - Clinical Implications
Ballroom D
2:00-3:00 - Science Session
Moderator:
- David Warburton MD, FRCP, DSc, Children's Hospital Los Angeles
Speakers:
- Laura Perin, PhD, Children’s Hospital Los Angeles
- Scott E. Fraser, PhD, California Institute of Technology
|
|
2:00
|
CONCURRENT SESSION
Cell Therapy and Pharmaceutical Industries-The Search for the New, New Thing
Ballroom E
2:00-3:00 - Industry Session
Moderator:
- Chris Mason MBBS, PhD, FRCS, University College London
Speakers:
- Alain Vertes PhD, London Business School
- Allen Eaves MD, PhD, FRCPC, Stemcell Technologies, Inc.
- Leanna Caron RPh, MBA, Genzyme Corporation
|
|
3:15
|
ADVOCACY Keynote Address
New Government and Philanthropic Paradigms for funding Stem Cell Research
Ballroom E
Robert Klein, JD, Chair Emeritus of the Governing Board, California Institute of Regenerative Medicine
3:15-3:45
|
|
3:45
|
Plenary Discussion:
The Mandate to Deliver Cures- Aligning patient advocacy, industry & science
Ballroom E
3:45-4:45
Moderator:
- Bernard Siegel JD, Genetics Policy Institute
Speakers:
- Danny Heumann, Heumannly Capable
- Paul Knoepfler PhD, University of California, Davis School of Medicine
- James C. Greenwood, Biotechnology Industry Organization
|
